Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: A companion study to cancer and leukemia group B 49907

Journal of Clinical Oncology

Volumn 29, Issue 8, 2011, Pages 1022-1028

  Kornblith, Alice B ^a   Lan, Lan ^a   Archer, Laura ^a   Partridge, Ann ^a   Kimmick, Gretchen ^a   Hudis, Clifford ^a   Winer, Eric ^a   Casey, Rebecca ^a   Bennett, Samantha ^a   Cohen, Harvey Jay ^a   Muss, Hyman B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

AGED; APPETITE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RELAPSE; CANCER SURVIVAL; CONSTIPATION; DIARRHEA; DISTRESS SYNDROME; EARLY STAGE BREAST CANCER; FATIGUE; FEMALE; HAND FOOT SYNDROME; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL STATUS; TELEPHONE; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; NEOPLASM STAGING; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79952772096     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.9859     Document Type: Article

References (15)

1. Muss HB, Berry DA, Cirrincione CT, et al: Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 360:2055-2065, 2009
2. Blum JL, Jones SE, Buzdar AU, et al: Multi-center phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 17:485-493, 1999 (Pubitemid 29075232)
3. Oshaughnessy JA, Blum J, Moiseyenko V, et al: Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate, and 5-fluououracil) as first-line therapy for advanced/metastatic breast cancer. Ann Oncol 12:1247-1254, 2001 (Pubitemid 32994752)
4. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993 (Pubitemid 23073154)
5. Sprangers MA, Groenvold M, Arraras JI, et al: The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a threecountry field study. J Clin Oncol 14:2756-2768, 1996 (Pubitemid 26329662)
6. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370, 1983 (Pubitemid 13098606)
7. Ibbotson T, Maguire P, Selby P, et al: Screening for anxiety and depression in cancer patients: The effects of disease and treatment. Eur J Cancer 30A:37-40, 1994 (Pubitemid 24058086)
8. Saykin AJ, Janssen RS, Sprehn GC, et al: Longitudinal evaluation of neuropsychologic function in homosexual men with HIV infection: 18-month follow-up. J Neuropsychiatry Clin Neurosci 3:286-298, 1991
9. Siegel K, Raveis VH, Mor V, et al: The relationship of spousal caregiver burden to patient disease and treatment-related conditions. Ann Oncol 2:511-516, 1991
10. National Cancer Institute Cancer Therapy Evaluation Program: Common Toxicity Criteria, 2008. http://ctep.cancer.gov/reporting/ctc.html
11. Katzman R, Brown T, Fuld P, et al: Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry 140:734-739, 1983 (Pubitemid 13094139)
12. Fillenbaum GG: Multidimensional Functional Assessment of Older Adults: The Duke Older Americans Resources and Services Procedures. Hilldale, NJ, Lawrence Erlbaum Associates, 1988
13. Sherbourne CD, Stewart AL: The MOS social support survey. Soc Sci Med 32:705-714, 1991
14. Holland JC, Herndon J, Kornblith AB, et al: A sociodemographic data collection model for cooperative clinical trials. Proc Am Soc Clin Oncol 11:157, 1992 (suppl; abstr 445)
15. Derogatis LR, Morrow GR, Fetting J, et al: The prevalence of psychiatric disorders among cancer patients. JAMA 249:751-757, 1983 (Pubitemid 13186788)